Clinical Trial Update: Pembrolizumab-PET Imaging [NA]

View source ↗

Summary

This clinical trial update notes the completion of a pembrolizumab-PET imaging study involving melanoma and non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Melanoma, Non-small Cell Lung Cancer | NA | Status: COMPLETED